The chemical reactions and pathways resulting in the breakdown of butirosin.

Combining with cholecystokinin and transmitting the signal across the membrane by activating an associated G-protein to initiate a change in cell activity. Cholecystokinin can act as a neuropeptide or as a gastrointestinal hormone.

The chemical reactions and pathways resulting in the formation of butirosin.

Combining with the neurotransmitter dopamine to initiate a change in cell activity.

Neurotransmitter receptor activity occuring in the postsynaptic membrane during synaptic transmission.

The chemical reactions and pathways involving beta-L-Ara4N-lipid A.

Combining with an icosanoid to initiate a change in cell activity.

Combining with a prostanoid, any compound based on or derived from the prostanoate structure, to initiate a change in cell activity.

Combining with a prostaglandin (PG) to initiate a change in cell activity.

Combining with prostaglandin D (PGD(2)) to initiate a change in cell activity.

Combining with prostaglandin E (PGE(2)) to initiate a change in cell activity.

Combining with prostaglandin F (PGF (2-alpha)) to initiate a change in cell activity.

Any process that modulates the frequency, rate or extent of apolipoprotein binding.

Any process that modulates the frequency, rate or extent of protein binding.

Any process that stops, prevents or reduces the frequency, rate or extent of apolipoprotein binding.

Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.

Any process that modulates the frequency, rate or extent of cellular response to testosterone stimulus.

Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to testosterone stimulus.

Any process that activates or increases the frequency, rate or extent of apolipoprotein binding.